Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38Stephen D. Wiviott, Elliott M. Antman, Shaun G. Goodman et al.|Circulation|2008Cited by 757
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 DiabetesNeha J. Pagidipati, Jairo Cruz, Ildiko Lingvay et al.|JAMA|2023Cited by 93